Seasonal influenza virus vaccine intradermal - sanofi pasteur

Drug Profile

Seasonal influenza virus vaccine intradermal - sanofi pasteur

Alternative Names: Flu-ID; Fluzone ID; IDflu; Intanza; Intradermic influenza vaccine - sanofi aventis; Intradermic influenza vaccine - sanofi pasteur

Latest Information Update: 22 May 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator sanofi pasteur
  • Developer Sanofi Pasteur
  • Class Influenza virus vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Influenza virus infections

Most Recent Events

  • 01 Oct 2014 Sanofi Pasteur initiates enrolment in a phase IV trial for Influenza virus infections (Prevention, 2014-2015 season) in USA (NCT02258334)
  • 01 Jul 2014 Sanofi Pasteur completes a phase IV trial for Influenza virus infections (Prevention, 2013-2014 season) in USA (NCT01946438)
  • 01 Sep 2013 Sanofi Pasteur initiates enrolment in a phase IV trial for Influenza virus infections (prevention, 2013-2014 season) in USA (NCT01946438)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top